To demonstrate the therapeutic potential of extracellular vimentin vaccination, an efficacy study was performed in client-owned dogs with spontaneous transitional cell carcinoma (TCC) of the bladder. This evidence concerns the gene VIM and tarsal-carpal coalition syndrome.